| Literature DB >> 29748782 |
Yahia N Mabkhot1, Mohammed M Alharbi2, Salim S Al-Showiman2, Hazem A Ghabbour3,4, Nabila A Kheder5,6, Saied M Soliman7,8, Wolfgang Frey9.
Abstract
BACKGROUND: The synthesis of newEntities:
Keywords: Computational studies; Cytotoxic activity; DMF-DMA; Thiazoles; X-ray crystallography
Year: 2018 PMID: 29748782 PMCID: PMC5945573 DOI: 10.1186/s13065-018-0420-7
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Fig. 1ORTEP diagram of the thiazole 6. Displacement ellipsoids are plotted at the 40% probability level for non-H atoms
Scheme 1Synthesis of (Z)-ethyl 2-cyano-2-(4-methyl-3-phenylthiazol-2(3H)-ylidene) acetate (6)
Fig. 2Molecular packing of thiazole 6 viewed hydrogen bonds which are drawn as dashed lines along a axis
Scheme 2A suggested mechanism for the synthesis of thiazole derivative 11
Fig. 3ORTEP diagram of thiazole 11. Displacement ellipsoids are plotted at the 40% probability level for non-H atoms
Fig. 4Molecular packing of thiazole 11 viewed hydrogen bonds which are drawn as dashed lines
Fig. 5The optimized structure of the thiazoles 6 and 11
Fig. 6The correlations between the calculated and experimental bond distances of the thiazoles 6 and 11
Fig. 7The MEP figure of the thiazoles 6 and 11
Fig. 8The frontier molecular orbitals of the synthesized compounds 6 and 11 calculated at the B3LYP/6-31G(d,p) level
Viability values and IC50 of thiophenes 6 and 11 against HCT-116 Cell Line
| S. no | Sample concentration (μg/mL) viability % | |||||||
|---|---|---|---|---|---|---|---|---|
| 50 | 25 | 12.5 | 6.25 | 3.125 | 1.56 | 0 | IC50 (μg) | |
| Ref. D. | 23.08 | 27.35 | 43.59 | 53.85 | 69.23 | 82.54 | 100 | 5.38 |
| 6 | 39.43 | 58.15 | 79.51 | 86.42 | 92.63 | 96.47 | 100 | 35.9 |
| 11 | 23.81 | 42.96 | 60.34 | 74.89 | 86.93 | 94.57 | 100 | 19.9 |
Ref. D. reference drug (Vinblastine), S. No sample number